381
Views
45
CrossRef citations to date
0
Altmetric
Miscellaneous

Menopause and aging, quality of life and sexuality

International Menopause Society Expert Workshop 1–4 December 2006, Pisa, Italy

Pages 88-96 | Published online: 03 Jul 2009

Suggested reading

  • Ashraf M S, Vongpatanasin W. Estrogen and hypertension. Curr Hypertens Rep 2006; 8: 368–376
  • Buster J E, Kingsberg S A, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005; 105: 944–952
  • Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007; 115: 840–845
  • Cohen L S, Soares C N, Vitonis A F, Otto M W, Harlow B L. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006; 63: 385–390
  • Quality of Life and Pharmacoeconomics in Clinical Trials – An Introduction, J A Cramer, B Spilker. Lippincott-Raven, Philadelphia 1998
  • Davis S R, Davison S L, Donath S, Bell R J. Circulating androgen levels and self-reported sexual function in women. JAMA 2005; 294: 91–96
  • Davis S R, Goldstat R, Papalia M A, et al. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause 2006; 13: 37–45
  • Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med 2006; 3: 212–222
  • Feeny D. Preference-Based Measures: Utility and Quality-Adjusted Life Years. Oxford University Press, Oxford 2005
  • Freeman E W, Sammel M D, Lin H, Nelson D B. Associati ons of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006; 63: 375–382
  • Gambacciani M, Genazzani A R. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health. Gynecol Endocrinol 2006; 22: 115–116
  • Genazzani A R, Simoncini T. Timing is everything. Gynecol Endocrinol 2007; 23: 1–4
  • Genazzani A R, Pluchino N, Luisi S, Luisi M. Estrogen, cognition and female ageing. Hum Reprod Update 2007; 13: 175–187
  • Women's Sexual Function and Dysfunction. Study, Diagnosis and Treatment, I Goldstein, C Meston, S Davis, A M Traish. Taylor & Francis, London 2005
  • Graziottin A, Leiblum S R. Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition. J Sex Med 2005; 2(Suppl 3)133–145
  • Guyatt G H, Feeny D H, Patrick D L. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622–629
  • Heinemann L AJ, Schneider H PG. Quality of life assessment in the menopause. The Menopause: Endocrinologic Basis and Management Options5th edn., B A Eskin. Informa Healthcare, Oxford 2007; 79–85
  • Imwalle D B, Gustafsson J A, Rissman E F. Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiol Behav 2005; 84: 157–163
  • Kaufman J M, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005; 26: 833–876
  • Modena M G, Sismondi P, Mueck A O, et al. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas 2005; 52: 1–10
  • Nappi R. Sexuality and Menopause. Elsevier, Philadelphia 2006
  • Nieschlag E, Swerdloff R, Behre H M, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 2005; 28: 125–127
  • Nijland E, Davis S, Laan E, Schultz W W. Female sexual satisfaction and pharmaceutical intervention: a critical review of the drug intervention studies in female sexual dysfunction. J Sex Med 2006; 3: 763–777
  • Otte C, Hart S, Neylan T C, Marmar C R, Yaffe K, Mohr D C. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 2005; 30: 80–91
  • Ouyang P, Michos E D, Karas R H. Hormone replacement therapy and the cardiovascular system: lessons learned and unanswered questions. J Am Coll Cardiol 2006; 47: 1741–1753
  • Panjari M, Davis S R. DHEA therapy for women: effect on sexual function and wellbeing. Hum Reprod Update 2007, Jan 5 [Epub ahead of print]
  • Revicki D A, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000; 9: 887–900
  • Schmidt P J, Rubinow D R. Reproductive ageing, sex steroids and depression. J Br Menopause Soc 2006; 12: 178–185
  • Shifren J L, Braunstein G D, Simon J A, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682–688
  • Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005; 90: 5226–5233
  • Simoncini T, Mannella P, Genazzani A R. Rapid estrogen actions in the cardiovascular system. Ann N Y Acad Sci 2006; 1089: 424–430
  • Simoncini T, Mannella P, Fornari L, et al. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 2004; 145: 5745–5756
  • Spilker B. Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott-Raven. 1996
  • Stevenson J. Menopausal Hormone Therapy. Taylor & Francis, London 2005
  • Wilson I B, Cleary P D. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273: 59–65
  • Woods N F, Carr M C, Tao E Y, Taylor H J, Mitchell E S. Increased urinary cortisol levels during the menopause transition. Menopause 2006; 13: 212–221
  • Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006; 91: 4335–4343

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.